Search

You searched for "Prostatitis"

339 results found

Andrology (2016)

1 July 2016 | | URO - Andrology
Case 1 Image A. Image B. Who is the mythological figure depicted in image A and how does he relate to a urological emergency? Define priapism and list five causes. In the context of a patient presenting with priapism, what...
Robotic Urology book cover

Robotic Urology

4 May 2020 | | URO - Technology
This represents a well written and comprehensive tome covering virtually all aspects of kidney, bladder and prostate surgery. The opening chapters deal well with aspects relating to robotic anaesthesia, training and education which I suspect even the most experienced of...
The Journal of Urology cover image.

Increased use of active surveillance for men with intermediate risk prostate cancer

3 September 2021 | | URO - Urologic Oncology
The optimal management of men with intermediate risk prostate cancer remains unclear and continues to be debated. The authors interrogate the US National Cancer Database for 176,122 men diagnosed with intermediate risk prostate cancer between 2010 and 2016. Of these...

Nomograms – is it hide and seek?

1 September 2017 | | URO - Basic Science Research
Everyday new decision-making aids are being developed due to various advances in software technology. This article from the UK makes very interesting reading. The word ‘nomogram’ is derived from the Greek word translated as ‘law line’ or ‘alignment chart’. The...

RARP – novel uroflow stop test

1 July 2015 | | URO - Functional / Reconstructive Urology, URO - Urologic Oncology
More and more centres are doing robotic assisted radical prostatectomy (RARP) surgery for cancer of the prostate .This study from Montreal, Canada describes a simple and novel test to predict recovery of urinary continence after RARP. The uroflow stop test...

Penile clamp device – a new indication?

1 September 2015 | | URO - Andrology
This study originates from New Zealand and looks at men affected by post-prostatectomy incontinence (PPI). These patients are difficult to manage with the options of further surgery, indwelling catheters or pads. The aim of this questionnaire study (IIQ 7) was...

Focal therapy trials

6 November 2020 | | URO - Urologic Oncology
Men with localised prostate cancer have traditionally required whole gland treatment involving radical prostatectomy or radical radiation treatment, independent of disease location and size. Increasing evidence supports the use of active treatment only in those men diagnosed with prostate cancer...

Cystoplasty

3 March 2021 | | URO - Functional / Reconstructive Urology, URO - Trauma & Emergency
Case 1 A 48-year-old female, having previously had an augmentation ileocystoplasty 10 years ago, has been referred with right loin pain by the emergency department. A venous blood gas is performed shortly after triage with the following values: What is...

Redundant! Do urological surgeons have a future in treating urological cancers? RSM Urology Section Meeting

4 March 2024 | | URO - Urologic Oncology
December 2023 marked the latest RSM Urology Section event. Alongside the Winter Short Papers Prize presentations, the theme of the day was major urological cancers and the role of the urologist in patient management within the multidisciplinary team (MDT). We...

Artificial intelligence

1 March 2019 | | URO - Technology
Artificial intelligence concerns me. Generally, people still tend to be concerned that their livelihoods will be replaced by an all powerful, all knowing artificial intelligence (AI) system. This at a time when the world’s largest technology companies (Amazon, Google, Apple),...

Urinary incontinence in women – part 2: management

1 September 2015 | | URO - Functional / Reconstructive Urology
In the second part of our comprehensive overview of urinary incontinence (UI) the authors explore the plethora of treatment options for this complex condition. (Part 1 available here). Conservative management Initial treatment of incontinence should be conservative. Caffeine reduction and...

Trials offering cytoreductive surgery for men with de novo synchronous metastatic prostate cancer

8 November 2021 | | URO - Basic Science Research, URO - Urologic Oncology
Life expectancy in men diagnosed with de novo synchronous metastatic hormone-sensitive prostate cancer (mHSPC) has risen to a median of 4.8 years with upfront systemic agents (such as docetaxel) in addition to standard androgen deprivation therapy (ADT) [1-3]. Within this...